Abeona Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
CEOVishwas Seshadri
CEOVishwas Seshadri
Employees84
Employees84
HeadquartersCleveland, Ohio
HeadquartersCleveland, Ohio
Founded1974
Founded1974
Employees84
Employees84
ABEO Key Statistics
Market cap207.90M
Market cap207.90M
Price-Earnings ratio-2.91
Price-Earnings ratio-2.91
Dividend yield—
Dividend yield—
Average volume238.67K
Average volume238.67K
High today$7.69
High today$7.69
Low today$7.20
Low today$7.20
Open price$7.50
Open price$7.50
Volume386.26K
Volume386.26K
52 Week high$9.01
52 Week high$9.01
52 Week low$2.83
52 Week low$2.83